Login

Interview with Genasys CEO Richard S. Danforth on company developments and industry insights. 00:10:00

Share On Facebook Share On Twitter

Richard S. Danforth is the CEO of Genasys.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Sustaining Success: Spinning Mills MD on Global Yarn and Fabric Promotion at Asian Trade Exhibition|Mr. S. Dinakaran,Managing Director,Sambandam Spinning Mills Ltd.
00:10:00
The opposite of a stuffy BigLaw firm|John B Quinn,Partner,Quinn Emanuel Urquhart & Sullivan LLP
00:10:00
Post-Election Impact on Policy and Markets
00:10:00
Howard Capital Management, Inc. (HCM) is a SEC-Registered Investment Advisory Firm founded by Vance Howard, which offers professional money management services to private clients, financial advisors, and registered investment advisors through a suite of s
00:10:00
Forsee Power CEO Christophe Gurtner Rings in Stock Market Listing on November 3rd |Christophe Gurtner,CEO , Forsee Power SA.
00:10:00
Stephen Siderow, co-founder of BlueMountain Capital Management LLC, discusses his investment strategy focused on risk management and diversified portfolios.|Andrew Todd Feldstein is the Blue Mountain Capital Management's CEO
00:10:00
Invests in technical founders building the next generation of applications|Sarah Catanzaro,General Partner,Amplify Partners
00:10:00
Jonathan Rauch: Defending Free Thought in Modern Times|Jonathan Rauch,Professor,Institution in Washington
00:10:00
Ethan Jung's Journey to CTO of Abundo Wealth | Ethan Bernhagen-Jung - CTO of Abundo Wealth
00:10:00
Cascadia Minerals: Yukon Copper-Gold Exploration and 2024 Drilling Plans
00:10:00
The Role of Public and Private Strategies in Real Estate: Insights from J.P. Morgan's Strategic Investment Advisory Group
00:10:00
BlackRock Switzerland's CEO highlights how the pandemic has increased investor focus on the 'S' in ESG, while also discussing structured products for wealth managers.

© 2026 Nehu